Lipoprotein Analysis via Self-Generating Gradient Ultracentrifugation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for analyzing lipoprotein components in blood, such as the standard lipid panel, are inadequate as they often result in errors in LDL cholesterol measurement and fail to accurately identify emerging risk factors for cardiovascular disease due to assumptions about cholesterol content and lack of subgroup analysis, missing 50% of cardiovascular disease cases.
Innovation Solution
A method involving mixing a serum sample with a fluorescent dye and a self-generating gradient material, centrifuging the mixture, and analyzing it to directly measure lipoprotein particle numbers without assuming cholesterol content, allowing for accurate identification of lipoprotein subgroups and emerging risk factors.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If standard lipid panel methods are used to measure LDL cholesterol, then the test is simple and cost-effective, but measurement accuracy deteriorates due to assumptions about cholesterol content and lack of subgroup analysis
Solution Approach 1:
The invention segments lipoproteins into distinct subgroups (VLDL, IDL, LDL, HDL) based on density characteristics, allowing each subgroup to be measured separately rather than assuming uniform cholesterol content across all lipoproteins. This segmentation enables accurate particle number measurement for each subgroup, resolving the accuracy issue while maintaining practical test complexity through automated density gradient ultracentrifugation.
Solution Approach 2:
The invention replaces traditional enzymatic cholesterol measurement methods with density gradient ultracentrifugation combined with particle counting. This substitution eliminates the need for assumptions about cholesterol content by directly measuring particle numbers based on density characteristics, significantly improving measurement accuracy without requiring complex manual analysis.
2Measurement precision
If extended CDC sequential separation methods are used to identify lipoprotein subgroups, then measurement precision improves, but time consumption and cost increase significantly
Solution Approach 1:
The invention merges multiple separation steps into a single density gradient ultracentrifugation process that simultaneously resolves VLDL, IDL, LDL, and HDL subgroups based on their density characteristics. This consolidation achieves the same subgroup identification accuracy as extended sequential methods but reduces test time from days to hours while maintaining automated analysis.
Solution Approach 2:
The invention changes the separation parameter from sequential enzymatic analysis to density-based ultracentrifugation. By measuring density characteristics directly and using automated particle counting, the method achieves precise subgroup identification in a single test rather than requiring multiple sequential steps, significantly reducing time while maintaining or improving precision.
3Ease of operation
If cholesterol content assumptions are made for LDL measurement, then calculation simplicity is maintained, but measurement reliability deteriorates due to errors of 20% or larger
Solution Approach 1:
The invention replaces calculated LDL cholesterol values based on assumptions with direct particle number measurements using density gradient ultracentrifugation. By counting particles directly based on their density characteristics, the method eliminates calculation errors and provides reliable measurements without requiring simplifying assumptions about cholesterol content, while automated analysis maintains operational simplicity.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This method provides a more accurate assessment of cardiovascular disease risk by directly measuring lipoprotein particle numbers, reducing errors associated with traditional methods and enabling precise identification of lipoprotein subgroups, thus improving diagnosis and treatment.
Implementation Method 1
developing an analyzable mixture in a centrifuge tube under increased gravity via application of external centrifugal force
Implementation Method 2
mixing a serum sample with a fluorescent dye
Data Source
AI summary
A new lipoprotein analysis procedure based on the CDC gold standard, analytical ultra centrifugation, having dramatically reduced the time and cost to obtain a result with a self generating continuous gradient. The method allows quantification of the risk factors of cardiovascular disease based on particle numbers of the particles of various groups and subgroups of lipoproteins.